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BACKGROUND: To plan for cancer services in the future, the long view of cancer prevalence is essential. It might be suspected that 
cancer prevalence before tobacco and industrial revolution pollutants was quite different to today. METHODS: To quantify the degree 
to which cancer prevalence may be changing over time, the authors analyzed 143 skeletons from 6 cemeteries from the Cambridge area 
(6th- 16th centuries). Visual inspection coupled with screening using both plain radiographs and computed tomography scans was used 
to detect malignant lesions. RESULTS: A total of 3.5% of individuals showed evidence for metastases. Factoring in modern data for the 
proportion of those with cancer that die with bone metastases, this suggests a minimum prevalence of all cancers at the time of death in 
medieval Britain to be approximately 9% to 14% of adults. CONCLUSIONS: This figure compares with a 40% to 50% prevalence of cancer 
at the time of death for modern Britain. The difference may be explained by the effects of modern carcinogens, the spread of viruses that 
trigger malignancy, industrial pollutants, and longer life expectancy. Cancer 2021;127:3054-3059. © 2021 The Authors. Cancer published 
by Wiley Periodicals LLC on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons 
Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. 
LAY SUMMARY: 
• Until now, no one has been able to work out how common cancer was before the time people were exposed to tumor- inducing chemi-
cals from tobacco and industrial factories.
• In this novel study, the authors have determined the percentage of people living in medieval Britain who had cancer metastases to 
bone at the time of their death and then compared that with modern data.
• It was found that cancer was approximately 25% as common in medieval times as it is today.
• This article suggests cancer was much more widespread in medieval times than was previously realized. 
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INTRODUCTION
It is important that we understand how the prevalence of cancer is changing over time. Such knowledge helps both 
clinicians and politicians to know whether cancer incidence has changed over time and helps them in planning for the 
future. It also helps anthropologists and archaeologists to better understand the lives of people who lived in the past, by 
developing a more accurate disease profile for past societies.1 It has been found that the lifetime risk of developing cancer 
for those born in 1930 in Britain was 38.5% in men and 36.7% in women. In contrast, the risk for those born in 1960 
was 53.5% in men and 47.5% in women.2 Clearly, cancer as a whole became more common during this period. There 
is also evidence to suggest that, over time, some types of cancer are becoming more common, whereas others less so.1 
There are many potential reasons for these changes, including increasing life expectancy enabling cancers to develop in 
older people and changing environmental exposure to risk factors. Cancers may be triggered by carcinogenic compounds, 
infectious microorganisms (such as viruses, bacteria, and parasites), environmental sources of radiation, as well as random 
gene mutations.3- 7 Cancers are also more common in people with predisposing oncogenes in their genome.8,9 Although 
the impact of some of these factors can be estimated by comparing cancer risk in groups who have been exposed to a 
particular agent with those who have not (eg, smokers), this is not always an easy task (eg, when we consider the effects 
of passive smoking).
One key question that remains unanswered is to what extent the effects of tobacco smoking and the toxins 
and pollutants from industrialization have had on the risk of developing cancer. The best way we have to answer 
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this question would be to study data from before the 
Industrial Revolution of the 1700s and 1800s and be-
fore tobacco became available in Britain following the 
transatlantic settlement of the Americas by Europeans 
in the 1500s.10 Although historic texts do mention can-
cer in this time period, just the most advanced cases of 
malignancy would have been apparent to early medical 
practitioners, and their understanding of cancer only 
partially overlaps with modern views of this group of 
diseases.11,12 Because some diseases were associated 
with stigma in the past, the recorded cause of death in 
registers often reflected the preference of relatives rather 
than a physician’s diagnosis following a postmortem ex-
amination. This means prevalence data from medieval 
or early modern period written sources is just not com-
parable with modern data.13 In consequence, an archae-
ological approach is the only one where we can apply 
modern diagnostic concepts to past populations. There 
have been a number of attempts to do this, some for dis-
tinct populations and some by pooling data from differ-
ent populations where excavated human remains show 
lesions compatible with cancer.1,14- 18 However, such an 
approach would suggest cancer was rare in the past, af-
fecting less than 1% of the population. This is because 
such data only include individuals where lesions from 
cancer can be seen on the surface of the skeleton and it 
misses those with metastases located within bones.
To improve our estimates of the prevalence of can-
cer in pre- industrial societies, what is needed is a study 
that uses not only the visual analysis of human skeletal 
remains for lesions, but also screening for cancers within 
bone using radiological imaging.19 This would detect a 
much higher proportion of the cancers that were orig-
inally present in the population. Here, we present the 
first such study where plain radiographs and computed 
tomography (CT) scanning have been systematically 
applied to estimate the prevalence of cancer in Britain 
before the introduction of smoking and industrial rev-
olution pollutants. The novel data acquired provide a 
key piece of missing information that enables the long 
view to understanding change in cancer prevalence over 
time.
MATERIALS AND METHODS
We analyzed 143 adult skeletons from 6 medieval 
cemeteries from the Cambridge area (see Supporting 
Appendix). They came from the cemeteries at Edix Hill 
(6th- 7th century AD), Gamblingay (10th- 11th cen-
tury), Cherry Hinton (10th- 12th century), All Saints 
by the Castle parish church (10th- 14th century), the 
Augustinian friary (13th- early 16th century), and the 
Hospital of St John the Evangelist (13th- early 16th 
century). Very few excavated burials have perfect pres-
ervation of the whole skeleton; thus, the minimum 
inclusion criteria for the study were individuals with 
intact spinal column, pelvis, and femora because these 
have been shown to be most likely to contain metastases 
in individuals with cancer.20,21 Children were not in-
cluded in the study because their bones are not fully de-
veloped, and cancer is much less common in this stage 
of life. In total, 96 males, 46 females, and 1 of indeter-
minate sex met the criteria for inclusion in the study 
(see Supporting Appendix). The biological sex of each 
adult skeleton was estimated by examining the sexually 
dimorphic characteristics of the pelvis and cranium and 
through ancient DNA analysis when available (53 indi-
viduals).22,23 Age at death was estimated by examining 
the pubic symphysis, auricular surface of the pelvis, and 
sternal ends of the ribs following standard guidelines.24
The bones of each individual were cleaned of soil 
and visually inspected for lesions compatible with pri-
mary or metastatic tumors, be they osteolytic, blastic, 
or mixed. We paid special attention to the spine, pelvis, 
and both femora because these bones have been shown 
to most commonly contain metastases when malignancy 
is present.20,21,25 The femora, pelvis, and vertebrae were 
then imaged using plain radiographs (x- rays) and CT 
scans to detect malignant lesions that may not be ap-
parent on the bone surface and to aid in the diagnosis 
of suspicious lesions. CT was performed using a Nikon 
XT H 225 ST microCT scanner (140 kV, 100 µA, 708 
ms integration, 125 µm). The criteria we used to iden-
tify metastases on imaging included rounded or oval de-
struction of trabeculae and the inner surface of adjacent 
cortical bone with ill- defined margins for osteolytic 
metastases; and nodular, rounded, or oval lesions with 
thickened coarse trabeculae for sclerotic metastases. 
Lesions with mixed lytic and sclerotic characteristics 
should show sclerotic change with areas of osteolysis.21 
The imaging was assessed by 2 medically qualified cli-
nicians. Initially, the entire set of imaging was reviewed 
by a consultant orthopedic surgeon with 25 years of 
experience working with excavated human skeletal re-
mains in an archaeology department (P.D.M.). Images 
of all suspicious lesions were then reviewed by a consul-
tant musculoskeletal radiologist (A.L.), and a positive 
diagnosis of malignancy was only made if the second 
opinion agreed with the initial interpretation.
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RESULTS
In the 143 individuals in the study, 5 showed evidence 
for malignancy (Fig. 1). One probable middle- aged male 
from Edix Hill (PSN599) showed small lytic lesions 
throughout the skeleton suggestive of multiple myeloma. 
One elderly male from Gamblingay (PSN 807) had a lytic 
metastasis in the right iliac wing. Two individuals from 
the parish cemetery of All Saints by the Castle showed 
evidence for lytic metastases of variable sizes. One el-
derly male had lytic metastases in the iliac wings of the 
pelvis (PSN737), and a middle- aged to elderly male had 
multiple lytic lesions of the vertebrae, ribs, and pelvis 
(PSN796). A middle- aged adult male from the hospital 
of St John the Evangelist was noted to have lytic metasta-
ses to the iliac wings and ischium of the pelvis (PSN160).
Estimating Cancer Prevalence in This Population
We identified lesions suggestive of malignancy in 5 of 
the 143 individuals, indicating a minimum prevalence of 
3.5%. Clinical studies have shown that CT has approxi-
mately 75% sensitivity for detecting bone metastases.21 
If the same applies to pre- industrial populations (which 
seems plausible), then the minimum true prevalence 
of bone involvement could be approximately one- third 
higher, in the region of 4.7%. Approximately one- third 
to one- half of modern people who die with cancer have 
metastases to bone.26,27 This might therefore suggest a 
minimum prevalence of all cancers at the time of death 
in medieval Britain to have been approximately 9% to 
14% of adults.
DISCUSSION
In this study, we have screened the skeletal remains of 143 
medieval individuals for cancer by visual inspection of 
their bones coupled with imaging of the femora, pelvis, 
and vertebrae. In this way, we have been able to detect 
cases of malignancy that were not visible on the external 
aspect of the bones. Although plain radiographs have been 
used in skeletal remains from the 1900s as a screening 
tool in one published study,19 research on patients with 
cancer has shown CT to be much more sensitive than 
plain radiographs alone. That is because CT will pick up 
metastases within the medulla of bone, whereas destruc-
tion of cortical bone is required before the lesions become 
visible on plain radiographs.21 Other imaging modalities 
that have even higher sensitivity for detecting metastases 
in live patients, such as positron emission tomography, 
magnetic resonance imaging, and single- photon emission 
computed tomography,21 cannot be used in excavated 
human skeletal remains because they require the pres-
ence of bone marrow and an intact cardiovascular system. 
Therefore, CT appears to be the gold- standard approach 
in archaeological bone. This is the first ever study to apply 
CT scanning to apparently normal archaeological bones 
to assess where metastases may be present within. In con-
sequence, we found more cases of cancer than have past 
studies that relied on visual diagnosis alone.
We have used data from the oncology literature to 
estimate the true number of adults with cancer in the 
population by factoring in the sensitivity of CT scans in 
detecting metastases in bone and the percentage of people 
Figure 1. (A) Photograph of a lytic lesion from metastasis in the vertebral body of PSN796, a middle- aged to elderly male. (B) 
Computed tomography (CT) showing a round lytic lesion from metastasis in the body of a thoracic vertebra of PSN599, a male with 
likely multiple myeloma. (C) CT showing a round lytic lesion from metastasis in the pelvis of PSN737, an elderly male.
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with cancer who develop skeletal metastases. This sug-
gests a minimum prevalence of all forms of cancer at the 
time of death in the medieval population in the area of 
Cambridge to have been in the region of 9% to 14% of 
adults. This compares with modern data indicating 40% 
to 50% prevalence of cancer at the time of death for mod-
ern Britain.2
The estimated cancer prevalence of 9% to 14% of 
adults in these pre- industrial populations is much higher 
than was previously thought. This shows that malignancy 
would have contributed to the disease burden of past pop-
ulations in a much greater way than has been realized. 
Nevertheless, the figure of 9% to 14% is lower than preva-
lence in the 20th century and fits with the known increase 
in cancer prevalence noted over time.2 It seems likely that 
the pre- industrial prevalence was lower because tobacco 
had not been introduced to Britain from the Americas, 
and the pollutants from the industrial revolution did not 
yet exist. It is also possible that some of the viruses that 
can trigger cancer may also have been less widespread in 
medieval Britain than they are in modern times now that 
long distance travel that can spread these organisms has 
become so much easier. When these factors are coupled 
with the longer life expectancy of modern populations be-
cause of improved hygiene, vaccination, and other health 
care improvements in recent times, the increase in cancer 
lifetime risk becomes understandable.
If we look at the types of cancer we identified, we see 
that one type had the appearance of multiple myeloma 
and the other four types were lytic metastases compati-
ble with other soft tissue organ malignancies. It can be 
highly challenging to determine the organ of origin for a 
cancer merely from the appearance of the skeletal lesions. 
In modern populations, 80% of skeletal metastases orig-
inate in cancer of the breast, lung, prostate, kidney, and 
thyroid.20 The incidence of metastatic bone disease varies 
considerably in different cancers, being roughly 95% to 
100% in myeloma, 65% to 75% in breast and prostate 
cancers, 60% in thyroid cancer, 30% to 40% in lung 
cancer, 20% to 25% in renal cancer, and 14% to 45% 
in melanoma.28 Although some metastases are predom-
inantly osteolytic (such as myeloma and breast cancer) 
and others are osteoblastic (such as prostate cancer), many 
others have both osteolytic and osteoblastic elements.26 
Because the metastases we identified were all lytic, this 
makes prostate cancer unlikely. Because the 5 individuals 
we identified with metastases were all males and the vast 
majority of those with breast cancer today are females, 
this might suggest breast malignancy was unlikely to be 
the cause. This leaves tumors of other tissues the most 
likely sources of origin, such as myeloma, lung, kidney, 
and thyroid.
Limitations of the Study
There will always be challenges facing studies that have to 
compare data calculated using different methods. Although 
we have tried to make allowances for the way the archaeo-
logical and clinical data have been acquired, there remains 
potential for these nonmatching data sources to have hid-
den errors compared with studies with matching data 
sources. For these reasons, we have given a plausible range 
(9%- 14%) for the minimum true prevalence of cancer in 
our medieval samples, without claiming undue accuracy.
In ideal circumstances, cancer prevalence is deter-
mined using as large a sample size as possible. Unlike 
modern studies where thousands of individuals are often 
included, we were limited to 143 medieval individuals be-
cause of the need for good preservation in the spine, pel-
vis, and femora of the available skeletons. Smaller sample 
sizes will inevitably lead to a larger margin of error.
Diagnosing cancer in excavated human skeletal re-
mains is more challenging than diagnosis in modern pa-
tients who can describe their symptoms, undergo physical 
examination, be assessed using a range of different types of 
imaging, have blood tests, and undergo biopsy and histol-
ogy. Other diseases during life can cause changes in bone 
that may mimic the lesions made by metastases, and the 
decomposition process (taphonomic change) can lead to 
destructive processes affecting bone after death. To give 
just 2 examples, bacterial infectious diseases may cause 
cavity formation within bone, whereas burrowing insects 
or tree roots could mimic destructive change from malig-
nancy.29,30 For these reasons, we only included cases where 
all the evidence (visual appearance and imaging) indicated 
malignancy as the most likely diagnosis. Having the diag-
nosis made with duplicate osteologists expert in diagnosing 
pathology in human skeletal remains (P.D.M. and J.D.) as 
well as the imaging undergoing duplicate reporting by clini-
cians who regularly deal with patients with cancer (P.D.M. 
and A.L.) should optimize our accuracy. This means the 
true prevalence of cancer in the medieval sample could have 
been higher than our estimate because some of the equivo-
cal cases we excluded could have been genuine malignancy.
Bone containing lytic metastases may be more prone 
to decomposition in the soil than otherwise healthy bone 
that will be stronger. Therefore, it is possible that indi-
viduals with multiple lytic metastases may be underrep-
resented in the archaeological record because of failure of 
preservation. This could again lead us to underestimate 
the true prevalence of cancer in the past.
A Note From History
3058 Cancer  September 1, 2021
By chance, there were a larger number of males in-
cluded in the study than females (96 males, 46 females, 1 
indeterminate sex). This is purely because we studied all 
the remains that were available to us that met the study 
criteria. This ratio helps to explain why the cases of can-
cer we did find were in males. For this reason, we should 
not extrapolate from our data that cancer may have been 
more common in males than females in the past.
We have estimated the likely prevalence for all cancers 
in our medieval samples based on modern data for the pro-
portion of different cancers that metastasize to bone. It is 
possible that the proportion of cancers from different organs 
may have been different in the past to that found today. 
If so, then the proportion of individuals with cancer who 
went on to develop bony metastases could also be different 
in the medieval period compared with today. This could 
mean that the true prevalence for all cancers in the medieval 
period could have been a little lower or higher than our esti-
mate, without us being aware of this error. Variation in true 
prevalence may well also have differed across other regions 
of the world (eg, depending on which infectious diseases 
that induce cancer were endemic in the past).
In this study, we focused on the analysis of adults 
from the medieval period. We were unable to include me-
dieval data for children who may have suffered from hema-
tological malignancies such as leukemia because untreated 
children with these conditions often die too rapidly for 
skeletal changes to develop. Although archaeological cases 
of leukemia in children are occasionally identified,16,31,32 
this challenge in identifying leukemia in human skeletal 
remains means this could have impacted our data for life-
time risk of developing cancer. However, in modern times, 
leukemia in children is extremely rare compared with most 
malignancies affecting adults,33 thus we do not anticipate it 
would have had a major impact on our prevalence results.
Concentrating our imaging on femur, pelvis, 
and spine does mean that individuals with cancer who 
only had metastases elsewhere would have been missed. 
However, only a small proportion of individuals fall into 
this category.19 If we had imaged the entire skeleton, the 
time available for the study would only have allowed us to 
include a small number of individuals, which would have 
made the study unviable.
Future Potential to Investigate Ancient Cancer 
Gene Mutations
As the ability to extract ancient DNA from the skeletal 
remains of past individuals improves, the potential arises 
for us to investigate past cancer genetics.34 One approach 
would be to analyze the human genome of skeletal remains 
to look for those genes that are known to be predisposed 
to the development of malignancy.8,9 To date, only 1 case 
study has been successful in doing this. Colonic tissue 
from an 18th century Hungarian mummy has revealed 
a mutation (E1317Q) in the adenomatous polyposis coli 
tumor suppressor gene, although the individual did not 
actually have colon cancer.35 If good- sized studies of the 
human genome could be undertaken in excavated human 
skeletal remains and predisposition gene prevalence were 
found to change over time, this could contribute to our 
understanding of the increasing prevalence of cancer 
noted in modern times. Another approach would be to 
compare the normal human genome in skeletal remains 
with that of the cancer from the same individual, fol-
lowing biopsy of cancer lesions identified in bones using 
imaging. Differences between the 2 would, in all proba-
bility, represent the mutations within the cancer that were 
responsible for its malignant behavior.36 A 15th century 
Italian mummy was noted to have adenocarcinoma of the 
colon, and biopsy enabled identification of a mutation 
of the K- ras gene commonly associated with this malig-
nancy.37 However, mummies are much less common than 
human skeletal remains, so if we are to investigate cancer 
in past populations, we will need to be able to do so using 
techniques that are effective in human skeletal remains 
to obtain sufficient sample size. This has the potential to 
show if there has been a change over time in the types of 
gene mutation that are triggering cancers and help us to 
plan for changing trends in mutations in the future.
Conclusion
This is the first ever study to use radiographs and CT 
imaging to create a plausible estimate of the prevalence 
of cancer in pre- industrial populations. Our results show 
cancer to have been much more common in medieval 
Britain than was previously thought. At an estimated 
minimum prevalence of 9% to 14% of adults, this shows 
cancer would have made a significant contribution to the 
disease burden of medieval societies.
The proportion of skeletal remains with visually ap-
parent malignant lesions was in line with past publica-
tions on the topic, at approximately 1%. The reasons we 
have been able to show cancer was more common than 
previously thought is first due to our use of imaging to 
detect lesions not visible on the bone surface, and second 
from our use of clinical data showing how the proportion 
of those with metastases relates to the entire body of indi-
viduals who develop cancer.
Diagnosing cancer in individuals who died hundreds 
of years ago is clearly a challenge. To minimize the risk of 
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error, we have carefully considered the differential diag-
nosis for each case, rejected those equivocal cases where 
diagnosis is possible but not secure, and double reported 
all skeletons and all imaging to optimize reliability. Such a 
stringent approach had probably led to us underestimat-
ing the true prevalence.
Our comparison of the medieval data with the prev-
alence of cancer during the 20th century indicates that 
cancer prevalence increased during the intervening pe-
riod. If it has changed from 9% to 14% of adults in the 
medieval period to 40% to 50% in modern times, this 
raises the question as to whether it will continue to in-
crease in prevalence in the future. Only time will tell.
FUNDING SUPPORT
This study was funded by the Wellcome Trust (collaborative grant 
200368/Z/15/Z).
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
AUTHOR CONTRIBUTIONS
Piers D. Mitchell: Conceptualization, methodology, investigation, data 
curation, formal analysis, funding acquisition, writing– original draft, and 
writing– review and editing. Jenna M. Dittmar: Methodology, resources, 
investigation, data curation, visualization, writing, and review and edit-
ing. Bram Mulder: Investigation, data curation, and writing– review and 
editing. Sarah Inskip: Resources and writing– review and editing. Alastair 
Littlewood: Investigation and validation. Craig Cessford: Resources, 
writing– original draft, and writing– review and editing. John E. Robb: 
Funding acquisition, project administration, and writing– review and editing.
REFERENCES
 1. Waldron T. What was the prevalence of malignant disease in the past? 
Int J Osteoarch. 1996;6:463- 470.
 2. Ahmad AS, Ormiston- Smith N, Sasieni PD. Trends in the lifetime risk 
of developing cancer in Great Britain: comparison of risk for those born 
from 1930 to 1960. Br J Cancer. 2015;112:943- 947.
 3. Ewald PW. Ancient cancers and infection- induced oncogenesis. Int J 
Paleopath. 2018;21:178- 185.
 4. Plummer M, de Martel C, Vignat HJ, Ferlay J, Bray F, Franceschi S. 
Global burden of cancers attributable to infections in 2012: a synthetic 
analysis. Lancet Global Health. 2016;4:e609- e616.
 5. Purdue MP, Hutchings SJ, Rushton L, Silverman DT. The propor-
tion of cancer attributable to occupational exposure. Ann Epidemiol. 
2015;25:188- 192.
 6. Rifkin RF, Potgieter M, Ramond J- B, Cowan DA. Ancient oncogene-
sis, infection and human evolution. Evolut Applic. 2017;10:949- 964.
 7. Van Tongeren M, Jimenez AS, Hutchings SJ, MacCalman L, Rushton 
L, Cherrie JW. Occupational cancer in Britain: exposure assessment 
methodology. Br J Cancer. 2012;107:S18- S26.
 8. Rahman N. Realising the promise of cancer predisposition genes. 
Nature. 2014;505:302- 308.
 9. Whitworth J, Smith PS, Martin J- E, et al. Comprehensive cancer- 
predisposition gene testing in an adult multiple primary tumour series 
shows a broad range of deleterious variants and atypical tumour pheno-
types. Am J Hum Genet. 2018;103:3- 18.
 10. Burns E. The Smoke of the Gods: A Social History of Tobacco. Temple 
University Press; 2007:14- 35.
 11. Demaitre L. Medieval notions of cancer: malignancy and metaphor. 
Bull Hist Med. 1998;72:609- 637.
 12. Skuse A. Constructions of Cancer in Early Modern England. Palgrave 
McMillan; 2015.
 13. Mitchell PD. Retrospective diagnosis, and the use of historical texts for 
investigating disease in the past. Int J Paleopath. 2011;1:81- 88.
 14. David AR, Zimmerman MR. Cancer: an old disease, a new disease, or 
something in between? Nat Rev Cancer. 2010;10:728- 733.
 15. Hunt KJ, Roberts C, Kirkpatrick C. Taking stock: a systematic review 
of archaeological evidence of cancers in human and early hominin re-
mains. Int J Paleopath. 2018;21:12- 26.
 16. Molto E, Sheldrick P. Paleo- oncology in the Dakleh Oasis: case studies 
and an paleoepidemiological perspective. Int J Paleopath. 2018;21:96- 110.
 17. Nerlich AG, Rohrbach H, Bachmeier B, Zink A. Malignant tumours 
in two ancient populations: an approach to historical tumour epidemi-
ology. Oncol Reports. 2016;16:197- 202.
 18. Zink A, Rohrbach H, Szeimies U, et al. Malignant tumours in an an-
cient Egyptian population. Anticancer Res. 1999;19:4273- 4277.
 19. Rothschild BM, Rothschild C. Comparison of radiological and gross 
examination for detection of cancer in defleshed skeletons. Am J 
Physical Anthropol. 1995;96:357- 363.
 20. Hage WD, Aboulafia AJ, Aboulafia DM. Incidence, location, and di-
agnostic evaluation of metastatic bone disease. Orthop Clin North Am. 
2000;31:515- 528.
 21. O’Sullivan GJ, Carty FL, Cronin CG. Imaging of bone metastasis: an 
update. World J Radiol. 2015;7:202- 211.
 22. Brickley M, Buckberry J. Undertaking sex assessment. In: Mitchell PD, 
Brickley M, eds. Updated Guidelines to the Standards for Recording 
Human Remains. Chartered Institute for Archaeologists & British 
Association of Biological Anthropology and Osteoarchaeology; 
2017:33- 34.
 23. Inskip S, Scheib CL, Wohns AW, et al. Evaluating macroscopic sex es-
timation methods using genetically sexed archaeological material: the 
medieval skeletal collection from St John’s Divinity School, Cambridge. 
Am J Phys Anthropol. 2019;168:340- 351.
 24. O’Connell L. Guidance on recording age at death in adult human skel-
etal remains. In: Mitchell PD, Brickley M, eds. Updated Guidelines to 
the Standards for Recording Human Remains. Chartered Institute for 
Archaeologists & British Association of Biological Anthropology and 
Osteoarchaeology; 2017:25- 29.
 25. Kimura T. Multidisciplinary approach for bone metastases: a review. 
Cancers. 2018;10:156.
 26. Mundy GR. Metastasis to bone: causes, consequences and therapeutic 
opportunities. Nat Rev Cancer. 2002;2:585- 593.
 27. Rizzoli R, Body J- J, Brandi M- L, et al. Cancer- associated bone disease. 
Osteopor Int. 2013;24:2929- 2953.
 28. Arvelo F, Sojo F, Cotte C. Cancer and the metastatic substrate. eCancer. 
2016;10:701.
 29. Kirkpatrick CL, Campbell RA, Hunt KJ. Paleo- oncology: Taking stock 
and moving forward. Int J Paleopath. 2018;21:3- 11.
 30. Ragsdale BD, Campbell RA, Kirkpatrick CL. Neoplasm or not? 
General principles of morphologic analysis of dry bone specimens. Int 
J Paleopath. 2018;21:27- 40.
 31. Klaus HD. A probable case of acute childhood leukaemia: skeletal in-
volvement, differential diagnosis, and the bioarchaeology of cancer in 
South America. Int J Osteoarch. 2016;26:348- 358.
 32. Rothschild BM, Hershkovitz I, Dutour O, Latimer B, Rothschild C, 
Jellema LM. Recognition of leukaemia in skeletal remains: report and 
comparison of two cases. Am J Phys Anthropol. 1997;102:481- 496.
 33. Barrington- Trimis JL, Cockburn M, Metayer C, et al. Trends in child-
hood leukaemia incidence over two decades from 1992- 2013. Int J 
Cancer. 2017;140:1000- 1008.
 34. Nerlich AG. Molecular paleopathology and paleo- oncology: state 
of the art, potentials, limitations and perspectives. Int J Paleopath. 
2018;21:77- 82.
 35. Feldman M, Hershkovitz I, Sklan EH, Bar- Gal GK, Pap I, Szikossy I, 
Rosin- Arbesfeld R. Detection of a tumour suppressor gene variant pre-
disposing to colorectal cancer in an 18th century Hungarian mummy. 
PLoS One. 2016;11:e0147217.
 36. Alexandrov LB, Kim J, Haradhvala NJ, et al. The repertoire of muta-
tional signatures in human cancer. Nature. 2020;578:94- 101.
 37. Ottini L, Falchetti M, Marinozzi S, Angeletti LR, Fornaciari G. Gene- 
environment interactions in the pre- industrial era: the cancer of King 
Ferrante I of Aragon (1431- 1494). Hum Pathol. 2011;42:332- 339.
